Cyclophosphamide and fludarabine

( DrugBank: Cyclophosphamide, Fludarabine / KEGG DRUG: Cyclophosphamide, Cyclophosphamide, Fludarabine phosphate, Fludarabine )


4 diseases
IDDisease name (Link within this page)Number of trials
11Myasthenia gravis1
13Multiple sclerosis/Neuromyelitis optica1
IDDisease name (Link within this page)Number of trials
14Chronic inflammatory demyelinating polyneuropathy1
16Crow-Fukase syndrome1

11. Myasthenia gravis


Clinical trials : 525 / Drugs : 355 - (DrugBank : 80) / Drug target genes : 75 - Drug target pathways : 139 
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries

13. Multiple sclerosis/Neuromyelitis optica


Clinical trials : 3,898 / Drugs : 2,785 - (DrugBank : 360) / Drug target genes : 265 - Drug target pathways : 239 
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries

14. Chronic inflammatory demyelinating polyneuropathy


Clinical trials : 302 / Drugs : 231 - (DrugBank : 32) / Drug target genes : 16 - Drug target pathways : 67 
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries

16. Crow-Fukase syndrome


Clinical trials : 19 / Drugs : 24 - (DrugBank : 11) / Drug target genes : 6 - Drug target pathways : 83 
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries